Rockwell Medical (RMTI) Return on Capital Employed (2011 - 2026)
Rockwell Medical's (RMTI) quarterly Return on Capital Employed came in at 10.15% in Q1 2026, down 1141.0% YoY from 0.97% in Q1 2025, and down 3.25% on a QoQ basis from 9.83% in Q4 2025.
Rockwell Medical (RMTI) Return on Capital Employed (2011 - 2026) Analysis & Trends
Rockwell Medical (RMTI) has 16 years of Return on Capital Employed data on file, last reported at 10.15% in Q1 2026.
- Quarterly Return on Capital Employed fell 1141.0% year-over-year to 10.15% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 10.15% (down 1141.0% YoY) and the FY2025 annual result came in at 9.65%, down 1111.0% from the prior year.
- Return on Capital Employed fell to 10.15% in Q1 2026, from 9.83% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 1.42% in Q3 2024 to a low of 127.21% in Q1 2022.
- A 5-year average of 30.86% and a median of 17.99% in 2024 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2022 — Return on Capital Employed plunged 8304 bps — and 2023, when it soared 8654 bps.
- Tracing RMTI's Return on Capital Employed over 5 years: stood at 51.29% in 2022, then jumped by 64 bps to 18.66% in 2023, then surged by 107 bps to 1.38% in 2024, then slumped by 812 bps to 9.83% in 2025, then declined by 3 bps to 10.15% in 2026.
- The last three Return on Capital Employed figures came in at 10.15% (Q1 2026), 9.83% (Q4 2025), and 10.58% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 6.60% |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 17.16% |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 6.07% |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 22.04% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -0.29% |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 18.67% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 5.52% |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Rockwell Medical | 30.28 Mn | 5.49 Mn | 3.24 Mn | -9.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9.88% |
| Mar 31, 2026 | -10.15% |
| Dec 31, 2025 | -9.83% |
| Sep 30, 2025 | -10.58% |
| Jun 30, 2025 | -3.05% |
| Mar 31, 2025 | 1.26% |
| Dec 31, 2024 | 1.38% |
| Sep 30, 2024 | 1.42% |
| Jun 30, 2024 | -8.36% |
| Mar 31, 2024 | -17.99% |
| Dec 31, 2023 | -18.66% |
| Sep 30, 2023 | -33.83% |
| Jun 30, 2023 | -46.14% |
| Mar 31, 2023 | -40.67% |
| Dec 31, 2022 | -51.29% |
| Sep 30, 2022 | -62.11% |
| Jun 30, 2022 | -88.90% |
| Mar 31, 2022 | -127.21% |
| Dec 31, 2021 | -92.85% |
| Sep 30, 2021 | -76.20% |